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NEURAL REGENERATION RESEARCH 
PERSPECTIVE
Using organotypic hippocampal 
slice cultures to gain insight into 
mechanisms responsible for the 
neuroprotective effects of meloxicam: 
a role for gamma aminobutyric and 
endoplasmic reticulum stress 
This perspective aims to put into context the recent article by Landuc-
ci et al. (2018) on mechanisms involved in the neuroprotective effects 
of meloxicam on an organotypic hippocampal slice cultures (OHSCs) 
model. In vitro cell cultures are the main method for studying large 
quantities of homogeneous cells in an isolated environment. Thus, 
the use of primary dissociated neuron, astrocyte, oligodendrocyte, 
microglia, or endothelial cell cultures has become a standard method 
in many laboratories, contributing substantially to a reduction in the 
number of in vivo assays. Cell cultures allow many different types 
of assays to be performed in research laboratories, such as survival, 
proliferation, cell signaling, or studies about the influence of toxic or 
protective drugs. However, cell cultures do not reproduce the com-
plex cell interactions that occur in the whole organ (Humpel, 2015). 
Thus, other approaches, such as organotypic cultures, have been 
developed in recent decades to better align models with in vivo situa-
tions, with the goal of preserving the original structural and synaptic 
organization as much as possible. In this regard, the first studies were 
conducted using hippocampal slices from neonates at 2 to 23 days 
old. The slices were maintained in culture at the interface between 
air and a culture medium. They were then placed on a sterile, 
transparent, and porous membrane and stored in petri dishes in 
an incubator. This method yielded thin slices that remained one 
to four cell layers thick and were characterized by a well-preserved 
organotypic organization (Humpel, 2015).
Donor age is important for organotypic slice cultures, and many 
assays have been carried out to assess the maturity of the cultured 
slices. Thus, OHSCs that are prepared from 8-day-old rats and cul-
tured in proper membranes for 12–14 days in vitro allow the slices 
to become mature enough to perform experiments that mimic pro-
cesses that occur in vivo. Two weeks in culture guarantee that slices 
are not activated by endogenous release of calcium or glutamate, 
reactive astrogliosis is minimized, and the developing slices have 
the time to mature and stabilize intrinsic axonal projections. In this 
regard, slice maturation has been suggested to be associated with 
the development of new synapses and the stabilization of glutamate 
transmission (Gerace et al., 2016).
OHSCs have been used as a model for different types of study, 
such as neurodegeneration, neurotoxicity, and neuroprotection. In 
particular, OHSCs have been used as a model to study mechanisms 
of response that occur following cerebral ischemia in vivo, as well 
as the effects elicited by the return of blood flow to the brain after 
ischemia (known as reperfusion). Ischemia effects are mimicked by 
exposing OHSCs to oxygen-glucose deprivation (OGD) in a hypoxia 
chamber for selected periods of time, and reperfusion is mimicked by 
returning the slices to normoxic conditions, which are called reper-
fusion-like (RL) conditions. Effects of OGD in the OHSC model have 
been well characterized, and exposure to OGD for periods ranging 
from 20 to 40 minutes have shown that, after 24 hours of RL condi-
tions, there is a time-dependent and gradual increase of the injury in 
the hippocampal CA1 area that involves the selective apoptotic de-
generation of pyramidal cells. A period of 30 minutes of OGD allows 
evaluating the effects of drugs that attenuate CA1 injury, as well as 
those that produce an aggravation of OGD toxicity (Llorente et al., 
2015; Landucci et al., 2018). 
Inflammation plays a crucial role in ischemic brain injury. The 
brain damage induced by ischemia triggers an increase in microglial 
and astrocyte activity; an increase in the production of cytokines, 
chemokines, adhesion molecules, and metalloproteinases; and the 
infiltration of monocytes and leukocytes in damaged brain regions. 
The role of inflammation in the ischemic process is controversial be-
cause a substantial proportion of the inflammatory response seems to 
aggravate the ischemic lesion, while certain inflammatory responses 
are beneficial (Kawabori and Yenari, 2015). Therefore, it is necessary 
to identify harmful and beneficial inflammatory responses to design 
therapeutic strategies that selectively inhibit harmful responses while 
improving the beneficial ones.
Cycloxygenases (COX) play a crucial role in the inflammatory re-
sponse that follows stroke. The role of COX-1 in stroke is unclear and 
seems to be dependent on the experimental model. While COX-1 de-
ficient mice result in worse outcomes when used in a middle cerebral 
artery occlusion model of brain ischemia, the inhibition of COX-1 
led to an increase in healthy neurons in the hippocampal CA1 region 
in a model of global cerebral ischemia. These discrepancies may be 
the result of differences in inflammatory responses between focal 
and global cerebral ischemia models. COX-2 is induced following 
brain ischemia. COX-2 inhibition or COX-2 deficient mice result in 
improved neurological outcome after stroke, and COX-2 overexpres-
sion leads to worse outcome (Kawabori and Yenari, 2015). Thus, the 
use of anti-inflammatory drugs as daily treatments or as treatments 
for ischemia should be meticulously reviewed.
Meloxicam, a COX-2 preferential non-steroidal anti-inflammatory 
drug, has been reported to lessen ischemic transcriptional effects in 
some glutamatergic system genes (see in Landucci et al., 2018), as 
well as to decrease infarct volume in in vivo assays (Jacobsen et al., 
2013). Interestingly, the presence of meloxicam in the incubation 
medium has been reported to decrease cell mortality in the OHSC 
model after 30 minues of OGD conditions, followed by 24 hours of 
RL conditions. The presence of meloxicam in the OHSC model also 
modifies the expression of different glutamatergic genes involved in 
excitotoxicity induced by OGD (Llorente et al., 2015). Overall, the 
study of Llorente et al. (2015) shows that meloxicam is able to pro-
vide neuroprotection independently of the systemic inflammatory 
response.
In a recent report, the neuroprotective effects of meloxicam in the 
OHSC model have been confirmed and are thought to be directly 
related to gamma aminobutyric A (GABAA) receptors. The authors 
report that blocking the GABAA receptor, either with bicuculline 
(Figure 1) or with gabazine, results in loss of the neuroprotective 
effects of meloxicam (Landucci et al., 2018), giving additional sup-
port to the previously described role of the GABAergic system in the 
effects of non-steroidal anti-inflammatory drugs (Bhattacharya et al., 
2014). Landucci et al. (2018) also indicate that the neuroprotective 
effects of meloxicam rely on the decrease of apoptosis, one of the 
OGD-induced types of regulated cell death subroutines. Interestingly, 
the study of Landucci et al. (2018) reveals that the blocking of GABAA 
receptors does not significantly increase apoptosis, which indicates 
that bicuculline elicits other type of cell death subroutines. The effects 
of meloxicam on apoptosis seem to depend on the cell line where 
the assays are performed (Fosslien, 2000), and the information of 
the effects of this agent in the central nervous system are very scarce. 
Thus, OHCS appears to be an interesting model for the study of the 
neuroprotective effects of meloxicam, its interactions with GABAA 
receptors, and the role of different cell death subroutines linked to 
OGD in the central nervous system. 
Post-ischemic release of GABA, and the subsequent activation of 
GABA receptors, have been suggested as a contributor to the attenu-
ation of post-ischemic neuronal damage (Cozzi et al., 2002). Differ-
ent levels of GABA have been reported to play an important role in 
the responses mediated through GABAA. Thus, high levels of GABA 
elicit transient inhibitory responses (that is, phasic responses) me-
diated by the rapid activation of postsynaptic GABAA receptors. 
In contrast, continuous low levels of GABA activate extrasynaptic 
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GABAA receptors, which results in persistent inhibition of neuronal 
excitability (tonic response). The peri-infarct area in the cerebral 
cortex has been reported to present a tonic rather than a phasic 
neuronal inhibition after stroke (Clarkson et al., 2010). This finding 
led Landucci et al. (2018) to analyze the pattern of transcription of 
GABAA α1, β2, and γ3 subunits in the OHCS model. They found that 
OGD modifies the pattern of expression of these receptors, which 
suggests the modification of GABAA receptor isophorms as a mech-
anism of response to ischemic damage. The modifications in the 
GABAA subunit transcriptional pattern induced by the presence of 
meloxicam provides additional support to this idea and suggests that 
the neuroprotective effects of meloxicam are related to changes in 
GABAA receptors (Landucci et al., 2018).
In recent years, several reports have described the inflammatory 
response and its interplay with endoplasmic reticulum stress and 
its associated unfolded protein response (UPR). The importance of 
this relationship and the ability of anti-inflammatory agents or en-
doplasmic reticulum-stress modulators to modify both responses, 
have been also highlighted after ischemic stroke (Llorente et al., 
2013). Endoplasmic reticulum stress is a condition that results from 
the accumulation of unfolded proteins, and it is one of the major 
imbalances induced by cerebral ischemia. Endoplasmic reticulum 
stress leads to the UPR, a complex cellular response that attempts to 
restore homeostasis by blocking protein synthesis and promoting 
the expression of proteins, such as chaperones, that help to correctly 
fold proteins (Schroder and Kaufman, 2005). Meloxicam has been 
described as being related to the UPR in an in vivo global cere-
bral model (Llorente et al., 2013). Whether meloxicam is able 
to directly stimulate the UPR or whether it is dependent on the 
systemic anti-inflammatory response is analyzed in the OHCS 
model (Landucci et al., 2018). Landucci et al. (2018) evaluate the 
early UPR response elicited by protein kinase RNA-like ER kinase 
(PERK) (Schroder and Kaufman, 2005) and report that meloxi-
cam is able to decrease ER stress (Figure 1) by maintaining the 
phosphorylation of eIF2alpha. They also suggest a progressive in-
crease in the levels of ER stress during RL conditions that would 
be alleviated by meloxicam. Thus, meloxicam seems to be able to 
directly stimulate UPR independently of its systemic effect.
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Figure 1 Meloxicam and bicuculline effects on oxygen and glucose 
deprivation (OGD).
Meloxicam decreases cell death and endoplasmic reticulum stress in the or-
ganotypic hippocampal slice culture model after 30 minutes of OGD condi-
tions, followed by 24 hours of reperfusion-like (RL) conditions. Bicuculline, 
an antagonist of gamma aminobutyric A receptors blocks the neuroprotec-
tive effects of meloxicam.
